+
Site Tour

AV Summit Valves 2024 | Closing of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Watch on Demand videos on AV Valves Summit 2024

Related Videos

Case Transmission | Tricuspid focus

Screening Transmission | Mitral focus

AV Valves Summit 2024 | Closing of Day 1

Navigating the Anatomy | Tricuspid focus

Trending Controversies | AV Valves

PremiClose 2024: Optimizing care

PCR London Valves 2022 – Treatment of Mitral Valve disease

Review the Trends | Tricuspid focus

LAAO Summit 2022: Live case: Denmark

PCRLV 2022: Tricuspid valve intervention

Echo course tricuspid TEER – patient selection

LAAO Summit 2022: The big dilemma 3

M-TEER: patient selection and current evidence

TRENDING TOPICS

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

CONNEXT


HUB
RELATED RESOURCES

ESC 2021: HF & VHD Guidelines

ACC 2023: COAPT™ trial

ESC 2022: FMR

PDA Patient Guide

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit 2023: Anatomy & imaging – Panel

AV VALVES 2023:Decision Making in HF – Mitral

AV VALVES 2023: The Genesis of TEER

PremiClose 2024: Neo-Ped Cardio Team

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline